Novartis AG (NYSE:NVS)

85.89
Delayed Data
As of Jun 05
 +0.77 / +0.90%
Today’s Change
69.18
Today|||52-Week Range
99.84
-9.29%
Year-to-Date
Lonza Swipes a Top Roche Executive to Be Its Next CEO
Jun 05 / MotleyFool.com - Paid Partner Content
The Debate Is Over: This Cancer Stock Is Winning the GIST Race
Jun 03 / MotleyFool.com - Paid Partner Content
Pliant Therapeutics Up 33% on IPO Pricing
Jun 03 / MotleyFool.com - Paid Partner Content
Novartis to Manufacture Mass General's Coronavirus Vaccine Candidate
May 28 / MotleyFool.com - Paid Partner Content
Better Buy: CRISPR Therapeutics vs. Intellia
Jun 03 / MotleyFool.com - Paid Partner Content
Is Coherus BioSciences a Buy?
May 26 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close85.12
Today’s open85.67
Day’s range85.54 - 86.44
Volume1,533,296
Average volume (3 months)2,578,938
Market cap$200.2B
Data as of 4:00pm ET, 06/05/2020

Growth & Valuation

Earnings growth (last year)-43.54%
Earnings growth (this year)+5.68%
Earnings growth (next 5 years)+8.34%
Revenue growth (last year)-8.60%
P/E ratio26.6
Price/Sales4.62
Price/Book3.57

Competitors

 Today’s
change
Today’s
% change
PFEPfizer-0.03-0.08%
MRKMerck+0.71+0.87%
ABBVAbbVie+0.79+0.85%
LLYEli Lilly and Co-1.50-1.00%
Data as of 7:59pm ET, 06/05/2020

Financials

Next reporting dateJuly 21, 2020
EPS forecast (this quarter)$1.39
Annual revenue (last year)$47.5B
Annual profit (last year)$7.0B
Net profit margin15.04%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Basel, Basel-stadt (basle Town)

Forecasts